Amgen Inc.

NASDAQ: AMGN · Real-Time Price · USD
296.52
6.23 (2.15%)
At close: Aug 15, 2025, 3:59 PM
296.47
-0.02%
After-hours: Aug 15, 2025, 05:49 PM EDT

Amgen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
34.91B 34.13B 33.42B 32.53B 30.93B 29.53B 28.19B 26.83B 26.58B 26.19B 26.32B 26.33B 26.38B 26.32B 25.98B 25.77B 25.48B 25.16B
Cost of Revenue
12.4B 12.63B 12.86B 12.86B 11.35B 9.93B 8.45B 7.09B 6.87B 6.57B 6.41B 6.38B 6.4B 6.53B 6.45B 6.33B 6.29B 6.14B
Gross Profit
22.5B 21.5B 20.57B 19.68B 19.58B 19.6B 19.74B 19.75B 19.71B 19.63B 19.92B 19.95B 19.99B 19.79B 19.52B 19.43B 19.2B 19.03B
Operating Income
8.18B 7.45B 7.26B 6.22B 6.19B 6.97B 7.9B 8.86B 9.49B 8.99B 9.57B 9.64B 9.36B 8.01B 7.64B 7.34B 7.42B 8.91B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 187M 187M 187M
Pretax Income
7.42B 6.65B 4.61B 4.68B 3.52B 4.34B 7.86B 8.75B 9.2B 9.11B 7.35B 7.73B 7.49B 6.52B 6.7B 6.45B 6.5B 7.97B
Net Income
6.62B 5.93B 4.09B 4.23B 3.13B 3.76B 6.72B 7.57B 7.98B 7.92B 6.55B 6.83B 6.58B 5.72B 5.89B 5.61B 5.75B 7.08B
Selling & General & Admin
6.88B 6.97B 7.1B 7.49B 7.22B 6.73B 6.18B 5.48B 5.41B 5.44B 5.41B 5.27B 5.29B 5.34B 5.37B 5.72B 5.76B 5.67B
Research & Development
6.4B 6.11B 5.96B 5.77B 5.4B 5.07B 4.78B 4.57B 4.61B 4.53B 4.43B 4.46B 4.77B 4.81B 4.82B 4.7B 4.34B 4.22B
Other Expenses
885M 973M 248M 192M 765M 836M 879M 840M 201M 661M 503M 588M 575M 1.63B 1.7B 1.68B 1.68B 225M
Operating Expenses
14.32B 14.05B 13.31B 13.46B 13.39B 12.63B 11.84B 10.89B 10.22B 10.64B 10.35B 10.31B 10.63B 11.78B 11.89B 12.09B 11.78B 10.12B
Interest Expense
2.95B 3.05B 3.15B 3.23B 3.21B 3.16B 2.88B 2.47B 2.08B 1.65B 1.41B 1.33B 1.25B 1.21B 1.2B 1.18B 1.19B 1.2B
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
26.73B 26.68B 26.17B 26.32B 24.74B 22.57B 20.29B 17.98B 17.09B 17.2B 16.76B 16.69B 17.03B 18.31B 18.34B 18.42B 18.07B 16.25B
Income Tax Expense
805M 717M 519M 449M 395M 582M 1.14B 1.19B 1.22B 1.2B 794M 894M 916M 796M 808M 838M 752M 885M
Shares Outstanding (Basic)
538M 538M 540.52M 537M 537M 536M 535M 535M 535M 534M 535M 535M 535M 548M 562M 567M 573M 577M
Shares Outstanding (Diluted)
541M 541M 542M 542M 541M 536M 540M 538M 537M 538M 539M 538M 537M 551M 565M 570M 576M 581M
EPS (Basic)
12.31 11.04 7.61 7.88 5.84 7.03 12.56 14.15 14.93 14.81 12.18 12.54 11.85 10.20 10.36 9.76 9.89 12.15
EPS (Diluted)
12.23 10.96 7.55 7.81 5.81 7.00 12.49 14.07 14.83 14.71 12.11 12.47 11.80 10.16 10.31 9.71 9.83 12.07
EBITDA
15.9B 15.28B 13.36B 13.48B 11.81B 12.07B 14.8B 14.82B 14.82B 14.24B 12.17B 12.41B 12.12B 11.12B 11.3B 11.05B 11.15B 12.72B
EBIT
10.38B 9.7B 7.76B 7.91B 6.74B 7.5B 10.73B 11.22B 11.27B 10.77B 8.75B 9.05B 8.75B 7.73B 7.9B 7.63B 7.68B 9.17B
Depreciation & Amortization
5.52B 5.58B 5.59B 5.58B 5.07B 4.57B 4.07B 3.6B 3.54B 3.48B 3.42B 3.36B 3.37B 3.4B 3.4B 3.42B 3.47B 3.54B